TIFAB
TRAF-interacting protein with FHA domain-containing protein B
Also known as: TIFAB_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q6ZNK6
- Gene
- TIFAB
- Ensembl
- ENSG00000255833
- Chromosome
- 5
- Canonical length
- 161 aa
- Protein class
- Predicted intracellular proteins
OverviewNCBI Gene
Predicted to enable deubiquitinase activator activity. Involved in several processes, including cochlea morphogenesis; cranial nerve development; and hard palate morphogenesis. [provided by Alliance of Genome Resources, Apr 2025]
Canonical amino-acid sequenceUniProt
161 residues, UniProt reviewed canonical sequence.
>Q6ZNK6|TIFAB
1 MEKPLTVLRV SLYHPTLGPS AFANVPPRLQ HDTSPLLLGR GQDAHLQLQL PRLSRRHLSL
61 EPYLEKGSAL LAFCLKALSR KGCVWVNGLT LRYLEQVPLS TVNRVSFSGI QMLVRVEEGT
121 SLEAFVCYFH VSPSPLIYRP EAEETDEWEG ISQGQPPPGS GLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TIFAB can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.35
- Highest tissue expression
- 5.3 nTPM
Expression across tissuesHPA
Tissue
- lymph node: 5.3 nTPM
- tonsil: 4.6 nTPM
- appendix: 3.5 nTPM
- spleen: 2.5 nTPM
- thymus: 1.8 nTPM
- rectum: 1.4 nTPM
Single-cell type
- pdcs: 30 nCPM
- cdc: 27 nCPM
- late spermatids: 16 nCPM
- monocyte progenitors: 5.5 nCPM
- late primary spermatocytes: 4.7 nCPM
- macrophages: 4.7 nCPM
Immune cell
- plasmacytoid DC: 14 nTPM
- myeloid DC: 4.5 nTPM
- intermediate monocyte: 1.2 nTPM
- classical monocyte: 0.5 nTPM
- total PBMC: 0.2 nTPM
- basophil: 0 nTPM
Brain region
- medulla oblongata: 0.2 nTPM
- white matter: 0.2 nTPM
- cerebellum: 0.1 nTPM
- hippocampal formation: 0.1 nTPM
- hypothalamus: 0.1 nTPM
- midbrain: 0.1 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.95
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.07
- DepMap mean gene effect
- -0.09
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- auditory behavior
- cellular response to cAMP
- cellular response to Thyroid stimulating hormone
- cochlea development
- cochlea morphogenesis
- craniofacial suture morphogenesis
- genitalia development
- genitalia morphogenesis
- hard palate morphogenesis
- hematopoietic progenitor cell differentiation
- inner ear development
- inner ear morphogenesis
- learned vocalization behavior
- lipopolysaccharide-mediated signaling pathway
- mastication
- myeloid cell differentiation
- negative regulation of canonical NF-kappaB signal transduction
- negative regulation of relaxation of muscle
- negative regulation of saliva secretion
- neuromuscular process controlling balance
- peristalsis
- positive regulation of canonical NF-kappaB signal transduction
- positive regulation of translation
- regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator
- regulation of muscle organ development
- thorax and anterior abdomen determination
- toll-like receptor signaling pathway
- trigeminal nerve development
- vestibulocochlear nerve formation
Molecular functions
- deubiquitinase activator activity
- ribonucleoprotein complex binding
- ubiquitin-specific protease binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
InteractionsUniProt · HPA
Protein binding partners of TIFAB in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TIFAB as an antibody target. Whether an autoantibody or antibody against TIFAB could matter depends on whether native TIFAB is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TIFAB is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TIFAB as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...